Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
- 1 March 2016
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 27 (3) , 544-545
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaNew England Journal of Medicine, 2015
- A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain MetastasesClinical Genitourinary Cancer, 2014
- Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trialsAnnals of Oncology, 2014
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012